BIOSIMILARS INDIA, Mumbai, 14th to 15th July 2011

BIOSIMILARS INDIA, Mumbai, 14th to 15th July 2011

 

About The Event

According to the latest statistics from Datamonitor the Indian biosimilars market is expected to grow to $580m by 2012. Although the biosimilars market is in its infancy, Indian manufacturers are well positioned to capitalise on the opportunities this future growth presents both domestically and internationally. However, there are plenty of challenges to be overcome before the benefits can be reaped. How prepared are you to navigate the ambiguous regulatory guidelines, undertake complex and expensive clinical trials, leverage inaccessible technological tools and access untapped markets?

CPhI Conferences is proud to announce its 2nd Annual Biosimilars India conference, bringing you all the very latest technical and strategic business-critical information you need to get your biosimilars to market. Building on the success of our 2010 event,Biosimilars India 2011 boasts a revised and refreshed agenda that deep-dives into the most timely R&D, manufacturing, regulatory and commercialisation challenges facing the biosimilars industry today!

The key highlights of this year’s information-packed agenda include:

  • Regulatory Developments – understand the impact of local and international regulatory requirements and the implications for your biosimilars strategy
  • R&D and Process Development – gain in-depth guidance on tackling complex R&D challenges to ensure the quality and safety of your biosimilars
  • Commercialisation – evaluate different partnership models and outsourcing strategies to drive the early profitability of your biosimilars business
  • Innovations – hear the latest on emerging technologies designed to reduce the timeframe and cost of your biosimilar product

Biosimilars India 2011 is a one-stop shop packed with implementable solutions designed specifically for VPs, Directors, GMs and Heads of Biologics, Biotechnology, R&D, Process Development, Formulations, Analysis and Testing, Regulation, and Product Development from: 

  • Biopharma Manufacturers
  • Biotechnology Manufacturers
  • Generic Pharma Manufacturers
  • Innovator Pharma Manufacturers
  • Equipment Suppliers
  • Ingredient & Material Suppliers
  • Analytical Laboratories
  • CRAMS

As our essential conference agenda and expert speaker line-up continue to take shape, ensure you check back for the latest updates and to take advantage of special early pricing rates.

Speakers:

Speakers already confirmed to present include:
 
KV Subramaniam,
President and Chief Executive Officer
Reliance Life Sciences
 
KV Anantharaman, 
Principal Analyst, Healthcare Research & Analysis
Datamonitor
 
Cyrus Karkaria,
President Biotech Division
Lupin Pharmaceuticals
 
Dhananjay Patankar, 
Vice President Biologics
Syngene International
 
Hareesh Parandhaman, 
Assistant Director Business Development
Lupin Pharmaceuticals
 
KK Tripathi, 
Adviser, Scientist ‘G’ and Member Secretary RCGM
Department of Biotechnology
 
Roger L Williams,
Chief Executive Officer
US Pharmacopoeia
 
Ganesh Kumraj,
President Operations
Bharat Serums and Vaccines
 
Smita Singhania, 
Vice President and Head, Regulatory Affairs
MabPharm
 
Rahul Padhye, 
Head of Corporate Development

Reliance Life Sciences
 
MS Mahadevan, 
Director, Strategic Marketing, Process Solutions Business Unit

Merck Millipore
 
Partha Ghosh, 
Director, Service Lead, Early Stage Development Europe
Parexel Consulting
 
Brij Patel, 
Deputy Manager, Biologicals and Biotechnology Unit
Medicines and Healthcare products Regulatory Agency (MHRA)

MK Sahib, 
Director Genomics and Biotechnology
Wockhardt

Rustom Mody, 
Chief Scientific Officer
Intas Biopharmaceuticals
 
Laxmi S Rao,
General Manager, Biotechnology Research Labs

USV
 
Mahesh Bhalgat,
Vice President
Biological E
 
Rustom Mody, 
Chief Scientific Officer
Intas Biopharmaceuticals
 
Vinod Kuberkar, 
Head Contract Services
Intas Biopharmaceuticals
 
Matthias Jöhnck, 
Head of Merck Millipore, Chromatography Research and Development, 

Merck, Darmstadt
 
Anil Kukreja, 
Director Medical Affairs

Roche Products India
 
Mahua Ganguly,
Head Medical Affairs
Biogen Idec, India

Invite friends

Contact Us

Page Views : 2194

Venue Map